Cibus Global LLC (CBUS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cibus Global LLC (CBUS) has a cash flow conversion efficiency ratio of -0.324x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-11.49 Million) by net assets ($35.48 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Cibus Global LLC (CBUS) balance sheet quality index to measure how much of total assets are equity-financed.
Cibus Global LLC - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Cibus Global LLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore CBUS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cibus Global LLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cibus Global LLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Global Lights Acquisition Corp Ordinary Shares
NASDAQ:GLACF
|
-0.003x |
|
RiTdisplay Corp
TW:8104
|
0.022x |
|
OptiNose
NASDAQ:OPTN
|
-0.027x |
|
Daechang Forgi
KO:015230
|
-0.004x |
|
Flexopack Société Anonyme Commercial and Industrial Plastics Company
AT:FLEXO
|
0.048x |
|
Centro de Imagem Diagnósticos S.A
SA:AALR3
|
0.071x |
|
Global Lights Acquisition Corp Ordinary Shares
NASDAQ:GLAC
|
-0.003x |
|
Edimax Technology Co Ltd
TW:3047
|
0.001x |
Annual Cash Flow Conversion Efficiency for Cibus Global LLC (2015–2025)
The table below shows the annual cash flow conversion efficiency of Cibus Global LLC from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Cibus Global LLC.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $21.83 Million | $-50.59 Million | -2.318x | -290.63% |
| 2024-12-31 | $97.83 Million | $-58.04 Million | -0.593x | -334.34% |
| 2023-12-31 | $338.29 Million | $-46.21 Million | -0.137x | +94.90% |
| 2022-12-31 | $7.23 Million | $-19.36 Million | -2.677x | -101.13% |
| 2021-12-31 | $14.13 Million | $-18.81 Million | -1.331x | -12.39% |
| 2020-12-31 | $36.88 Million | $-43.67 Million | -1.184x | -131.70% |
| 2019-12-31 | $62.51 Million | $-31.95 Million | -0.511x | -135.73% |
| 2018-12-31 | $93.40 Million | $-20.25 Million | -0.217x | +2.52% |
| 2017-12-31 | $57.48 Million | $-12.79 Million | -0.222x | +68.41% |
| 2016-12-31 | $13.12 Million | $-9.24 Million | -0.704x | -155.26% |
| 2015-12-31 | $24.26 Million | $-6.69 Million | -0.276x | -- |
About Cibus Global LLC
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-th… Read more